TCI GENE Inc. (TPEX:6879)

TCI GENE Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	136.79	250.69	98.43	696.05	932.74	326.19
Short-Term Investments	561.13	419.83	576.1	201.1	2.5	3.5
Trading Asset Securities	161.45	158.71	159.9	-	-	-
Cash & Short-Term Investments	859.36	829.23	834.43	897.15	935.24	329.69
Cash Growth	-2.78%	-0.62%	-6.99%	-4.07%	183.68%	85.67%
Accounts Receivable	59.82	44	95.66	102.59	73.08	116.9
Other Receivables	6.4	6.61	9.65	0.86	0.99	1.08
Receivables	66.21	50.61	105.31	103.45	74.06	117.98
Inventory	20.29	18.75	43.87	57.86	57.26	32.64
Prepaid Expenses	16.06	-	-	7.72	6.77	4.71
Other Current Assets	0.21	15.7	10.68	2.55	2.72	1.26
Total Current Assets	962.14	914.29	994.28	1,069	1,076	486.28
Property, Plant & Equipment	7.53	12.18	10.88	21.91	25.49	41.71
Long-Term Investments	72.38	75.23	70.72	60.65	49.26	18.69
Goodwill	-	1.47	1.47	1.47	1.47	1.47
Other Intangible Assets	3.25	2.1	3.08	4.21	4.88	4.47
Long-Term Deferred Tax Assets	-	2.19	-	-	-	-
Other Long-Term Assets	4.43	3.85	18.68	8.99	6.18	7.71
Total Assets	1,050	1,011	1,099	1,166	1,163	560.31

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	46.07	25.88	40.56	75.92	60.47	72.74
Accrued Expenses	-	34.26	24.43	32.61	32.61	29.48
Current Portion of Leases	3.29	6.32	-	6.21	1.88	6.83
Current Income Taxes Payable	1.78	1.83	12.3	10.67	21.9	23.89
Current Unearned Revenue	13.16	11.25	4.12	5.63	5.96	11.46
Other Current Liabilities	48.63	19.1	19.89	24.51	20.35	24.98
Total Current Liabilities	112.92	98.64	101.29	155.55	143.17	169.38
Other Long-Term Liabilities	-	-	-	-	-	0.06
Total Liabilities	112.92	98.64	101.29	155.55	143.17	169.44

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	264.59	264.59	264.59	264.59	264.59	214.59
Additional Paid-In Capital	602.96	602.96	607.77	604.76	595.78	47.68
Retained Earnings	114.26	101.11	113.46	83.61	124.85	106.35
Comprehensive Income & Other	-67.29	-78.15	-11.08	33.56	19.91	11.58
Total Common Equity	914.51	890.51	974.73	986.51	1,005	380.2
Minority Interest	22.3	22.15	23.08	23.88	15.04	10.67
Shareholders' Equity	936.8	912.65	997.81	1,010	1,020	390.88
Total Liabilities & Equity	1,050	1,011	1,099	1,166	1,163	560.31

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3.29	6.32	-	6.21	1.88	6.83
Net Cash (Debt)	856.07	822.9	834.43	890.94	933.36	322.86
Net Cash Growth	-1.76%	-1.38%	-6.34%	-4.54%	189.09%	81.83%
Net Cash Per Share	31.86	30.92	31.45	33.64	37.96	16.31
Filing Date Shares Outstanding	26.3	26.46	26.46	26.46	26.46	21.46
Total Common Shares Outstanding	26.3	26.46	26.46	26.46	26.46	21.46
Working Capital	849.22	815.65	892.99	913.17	932.88	316.9
Book Value Per Share	34.78	33.66	36.84	37.28	37.99	17.72
Tangible Book Value	911.26	886.94	970.19	980.84	998.78	374.27
Tangible Book Value Per Share	34.65	33.52	36.67	37.07	37.75	17.44
Machinery	-	53.78	53.5	74.82	74.08	68.03

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 24, 2026

Data Sources Report a data error